Glenmark reduces cost of Trastuzumab treatment in India
A 440 mg vial of Trumab will be priced at Rs 15,749, which makes it the most affordable option available currently in the country
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Glance in the future: Explore innovative solutions at PHARMAP 2023
PHARMAP 2023 gathered pharma companies, CMOs and CDMOs, governmental bodies to exchange experience in digital transformation and…
Development of universal influenza vaccines gaining precedence: GlobalData
The current influenza vaccines only provide protection against a limited number of strains
Samsung Biologics partners with Pfizer for manufacturing of biosimilars portfolio
Under the terms of the new agreement, Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing…
IPA to host eighth edition of Global Pharmaceutical Quality Summit in Mumbai
The theme for this year’s annual flagship event is ‘Patient Centricity: New Paradigm of Manufacturing and Quality’
Granules India gets USFDA approval for Metoprolol Succinate ER Tablets
Metoprolol Succinate ER Tablets are indicated for the treatment of hypertension in order to lower blood pressure
Pfizer and GSK to battle for share of new RSV vaccine market: GlobalData
Pfizer's RSV vaccine, Abrysvo, approved by the FDA just weeks after Arexvy, is likely to show GSK significant competition
USFDA inspects JB Pharma’s manufacturing facility at Panoli, Gujarat
The facility received no observations and no Form 483 was issued
Caplin Steriles gets USFDA nod for Cisatracurium Besylate injection
Cisatracurium Besylate Injection USP is a nondepolarising skeletal neuromuscular blocker, indicated as an adjunct to general…
Deal value decreased by 16 per cent in May 2023, compared to May 2022
The healthcare industry reported 125 VC deals worth $2.7 billion in May 2023, compared to the last 12-month average (May 2022 to…